Falnex

Falnex is a specialty pharmaceutical company headquartered in Ahmedabad, India, primarily focused on the oncology and critical care therapeutic segments. The company specializes in the development, marketing, and distribution of high-quality branded generic medicines, including complex injectables and oral formulations for various malignancies. Falnex's portfolio features essential cancer treatments such as Fulvestrant, Bortezomib, and Pemetrexed, aiming to provide cost-effective and accessible therapeutic options to patients. With a strong emphasis on quality assurance and a robust supply chain, the company serves healthcare providers across India and several emerging international markets. Falnex continues to expand its reach through strategic partnerships and the introduction of new specialty pharmaceutical products to its growing pipeline.